Overview

Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison

Status:
Completed

Trial end date:
2008-08-01

Target enrollment:

Participant gender:

Summary

This study will compare the tolerability of Quetiapine Fumarate immediate release formulation and Quetiapine Fumarate extended release formulation during initial dose escalation in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

AstraZeneca

Treatments:

Quetiapine Fumarate